Related Experiment Video
Updated: Mar 27, 2026

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
FTO-ACKR3 Axis Regulates Polycyclic Aromatic Hydrocarbons-Induced Asthma Attacks via AhR-Mediated m6A RNA Methylation
Shengbin Liu1, Jiangzhou Chu2, Jinxiu Xin1
1Institute of Systems Genetics, Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610000, China.
Abstract:
Airborne polycyclic aromatic hydrocarbons (PAHs) are increasingly linked to asthma onset and exacerbation, yet their molecular mechanisms remain unclear. Building on our previous finding that PM2.5 alters m6A RNA methylation, we hypothesized that PAHs drive asthma progression through epitranscriptomic regulation. Here, we show that PAH exposure aggravated lung injury, airway remodeling, and fibrosis while reducing global m6A levelsan effect reversed by AhR inhibition. Mechanistically, PAH-activated AhR suppressed transcription of the m6A demethylase FTO, leading to widespread hypomethylation. Reduced m6A deposition on ACKR3 mRNA enhanced its stability through IGF2BP1/2/3 binding, thereby increasing ACKR3 expression. Elevated ACKR3 promoted autophagy and inflammatory signaling in bronchial epithelial cells. Consistently, FTO-deficient mice displayed exacerbated airway inflammation, fibrosis, and ACKR3-driven autophagy. Moreover, PAHs activated the TNFα/NF-κB pathway, further amplifying autophagy and inflammation. Together, these findings define a previously unrecognized AhR-FTO-ACKR3 epitranscriptomic axis through which PAHs potentiate NF-κB signaling, autophagy, and airway injury, providing new mechanistic insight and potential therapeutic targets for pollution-driven asthma.
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...

